Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-04-28 00:00:00 ET · period of report 2023-04-26 · accession 0001415889-23-007004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-28 | 2023-04-26 | KNSA | Ragosa Mark | CFO | F - Tax | $11.15 | -291 | 12.4K | -2% | -$3,245 |
| D | 2023-04-28 | 2023-04-26 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +990 | 12.7K | +8% | — |
| D | 2023-04-28 | 2023-04-26 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | +990 | 1,981 | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-04-26 | F | D | 291 | $11.15 | 12,414 | D | — | — | |
| 2 | Common | Class A Common Share | 2023-04-26 | M | A | 990 | — | 12,705 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Derivative | Restricted Share Unit | 2023-04-26 | M | A | 990 | $0.00 | 1,981 | D | — · — to — | 990 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 26, 2021. |